• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Ray Page Details How Physicians Currently Use Data at the Point of Care

Video

Using oncology care pathways and treatment pathways has helped practices use evidence-based data to facilitate them to be sure they are using the right drug for the right patient at the right time, said Ray Page, DO, PhD, president and director of research at The Center for Cancer and Blood Disorders.

Using oncology care pathways and treatment pathways has helped practices use evidence-based data to facilitate them to be sure they are using the right drug for the right patient at the right time, said Ray Page, DO, PhD, president and director of research at The Center for Cancer and Blood Disorders.

Transcript

How are physicians using data at the point-of-care today?

We’re trying to increasingly use that kind of data at the point of care to help make behavior modifications for our physicians to help us identify some of these risk stratifiers that are occurring. Certainly 1 thing that our practice has done for many years is just the utilization of oncology care pathways and treatment pathways, and just being able to use that kind of evidence-based data to facilitate us in assuring that we’re using the right drug for the right patient at the right time, it goes a long way just utilizing treatments pathways.

I’ll emphasize also that as we find these quality measures and these benchmarks and these standards and these interventions that this is very much a team approach and as we take care of our cancer patients and get them through the journey with their cancer, we do have an entire team that manages those. There’s certain data elements that occur at the physician level that we manage but then there’s other data elements that will go to our advanced practitioners to manage.

Then there’s other data elements and processes that occur that go to our case managers and our triage nurses and our chemotherapy nurses and then all of our ancillary services that we have so that we can actually utilize everybody in the team to function at their highest level to assure that our patients are getting all the touches and the contacts that they need in order to have optimal outcomes.

Related Videos
Pat Van Burkleo
Jeff Stark, MD, vice president, head of medical immunology, UCB
Robert Groves, MD
Screenshot of Raajit Rampal, MD, PhD
 Laura Ferris, MD, PhD, professor of dermatology, University of Pittsburgh
Dr Padma Sripada, Columbia Internal Medicine
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
dr amy paller
Shawn Kwatra, MD, dermatologist, John Hopkins University
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.